Converge Bio Uses AI To Enhance Cancer Therapy With Single Prompt
Israeli startup Converge Bio enhanced cancer drug cetuximab using AI, generating 100,000 antibody candidates and identifying a stronger option.
Converge Bio
Israeli AI Startup Converge Bio Raises $25M to Transform Drug Discovery
Israeli AI startup Converge Bio secures $25 million Series A funding, bringing total to $30M for its AI drug discovery platform.
Navigation